Rotavirus Vaccine Completed Phase N/A Trials for Infections, Rotavirus / Prophylaxis Against Gastroenteritis Caused by Rotavirus

CompletedNot AvailableNot Available IdentifierTitleDrugs
NCT00353366To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
NCT00938327Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants
NCT01636739Special Drug Use Investigation for ROTARIX®
NCT01636193Drug Use Investigation for ROTARIX®
NCT00750893Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants